Bioventus Inc.
corporate_fare Company Profile
Bioventus Inc. (NASDAQ:BVS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for BVS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for BVS spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Bioventus 10-Q: Q3 Net Income $6.0M, Nine-Month Operating Cash Flow $49.5M, Debt Cut to $231.8M
- Bioventus Beats on Margins, Trims Sales Guidance as Strategic Review Continues
- Bioventus Misses Q2 Revenue, Launches Strategic Review, and Books Tax Benefit
- Bioventus Q2 Revenue Misses, Launches Strategic Review Including Potential Sale
- Bioventus Launches Strategic Review Including Potential Sale After Q2 Beat; Reaffirms 2026 Guidance
Financial Snapshot
Short Interest & Short Volume
6.62 days to coverFINRA reported short interest of 3,022,935 shares in BVS as of the October 30, 2026 settlement, a 4.9% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 56.7% of BVS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.